SOURCE: MDM Group, Inc

April 07, 2005 13:04 ET

Mdm Group Receives ISTC Partner Status for Biodefense Division

MDM to Gain Access to Top Russian Facilities and Biodefense Development Opportunities Through ISTC Partnership

SANTA CLARA, CA -- (MARKET WIRE) -- April 7, 2005 -- MDM Group, Inc. (OTC: MDDM) advises that it has received official notification of its registered status as "ISTC Partner". Partnership with the International Science and Technology Center (ISTC) provides MDM with clear access to accelerate its ongoing development of its biodefense capabilities in conjunction with world leading researchers and institutes in the Russian Federation.

The ISTC Program ( is part of a US Department of State program whose objective is to support nonproliferation in the area of nuclear, biological and chemical Weapons of Mass Destruction (WMD) by providing assistance in establishing sustainable non-weapon related jobs for the scientists and engineers in the Newly Independent States of the former Soviet Union who possess current or prior, direct or indirect WMD experience. The ISTC program is funded mainly by the US, European Union, and Japan.

Under the ISTC Partnership arrangement:

--  ISTC will provide MDM with access to its vast network of institutes
    throughout Russia and in six other neighboring countries;
--  ISTC will provide coordination and project management services as
    required by MDM;
--  Certain MDM projects will be eligible for risk-sharing arrangements to
    accelerate commercialization.
Since MDM's November 10, 2004 announcement of the establishment of its Biodefense Division, MDM's team has been developing its Biodefense strategy and evaluating several technology opportunities from sources around the world. Consistent with its original mandate, MDM's focus is on niche projects in countermeasure development that have progressed from basic research to the development state. Such products are expected to have shorter development time and be confirmed as needed by the US government. MDM's Biodefense Division expects to engage in its first project during the current quarter.

Dr. Ed Stephen, head of MDM's biodefense division, commented: "Our ISTC Partnership creates an immediate and important extension to the scientific capabilities and the facilities available to us. We are already well advanced in exploring specific opportunities in which ISTC can play a key role, saving us time and cost in some cases and introducing us to new intellectual property in other cases."

MDM Group is a development stage Company focused on the Security, Biodefense and Homeland Security industries See:

Safe Harbor Statement

The information in this release, other than historical information, may be considered forward-looking statements within the provisions of the Private Securities Litigation Reform Act of 1995. Projection and other forward-looking statements and management expectations regarding future events and/or financial performance of the Company -- although given in good faith -- are inherently uncertain and actual events and/or results may differ materially.

For further information see:

MDM Group is featured on a global investment research portal for defense and security.

Contact Information